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1. Introduction 
Recently we have described a plasmatic ‘ACTH 
binding factor’, which prevents adsorption of ACTH 
to silicates and binding of ACTH to a specific antibody 
[l]. As the activity of this factor differed from one 
plasma to the other, valid radioimmunology measure- 
ment was impossible in presence of plasma. Therefore 
we developed a simple method for extraction of ACTH 
from plasma using microfine precipitated silica granules 
(QUSO G 32), which adsorb ACTH well [6] leaving 
the binding factor in the supernatant [2]. 
The aim of the present study was to demonstrate 
whether or not this factor has any implication in the 
regulation of biological ACTH action. A model using 
isolated adrenal cells as described by Sayers et al. [3] 
seemed to be most appropriate. In the same manner 
as this factor competes with QUSO or an antibody for 
ACTH, it may compete with the receptor of the 
adrenal cell surface, thus inducing an inhibition of 
corticotrophic activity. 
2. Material and methods 
Isolated adrenal cells were prepared according to 
Sayers et al. [3]. Female rats (BW 150-180 g, strain 
FW 49 Kirchb. Bib. Lemgo) were used throughout. 
The final cell suspension contained 100 000-l 50 000 
cells/ml and 1 mg/ml trypsin inhibitor. Incubations 
were carried out for 2 hr at 37°C in a Warburg meta- 
* Supported by Deutsche Forschungsgemeinschaft, Bad 
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North-Holland Publishing Company - Amsterdam 
bolic shaker with 0.9 ml cell suspension, 0.1 ml ACTH 
solution and in some experiments an additional 0.1 ml 
heparin plasma or QUSO supernatant or QUSO-eluate 
from plasma. 
2.1. Extraction of ACTH from plasma 
1.5 ml plasma were stirred for 5 min with 1 .O ml 
QUSO suspension containing 50 mg QUSO in 0.125 M 
phosphate buffer (pH 7.4). After centrifugation the 
supernatant was discarded and the sediment washed 
briefly with 3.0 ml phosphate buffer (0.125 M, pH 7.4). 
The ACTH was eluted from the QUSO granules by 
stirring with 1.5 ml 0.1 HCl - 0.9% NaCl for 5 min. 
2.2. Estimation of ‘binding activity ‘of plasma 
0.5 ml Plasma were diluted I:5 in 0.02 M barbital 
buffer containing 400 KIU Trasylol/ml, and 0.02% 
mercaptoethanol to prevent incubation damage. After 
1 hr incubation at room temperature with [125J]~‘-3g- 
ACTH (labelling procedure has been described else! 
where [4] ), the ‘free’ ACTH was adsorbed to 50 mg 
talcum powder. It has been demonstrated previously 
that under these conditions degradation of [125J]ACTH 
was negligible [ 11. As ‘control plasma’ a 5% bovine 
serum albumin - 0.9% NaCl - solution (BSA-NaCl) 
was used. 
Hypophysectomy of rats was carried out by a 
semistereotactic transauricular method as described 
recently [5]. 
3. Results 
Addition of heparin plasma to the suspension of 
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Fig. 1. Influence of heparin plasma on ACTH-stimulated 
corticosterone production of isolated adrenal cells. The 
samples without plasma contained a 5% BSA-0.9% NaCl- 
solution instead. 
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Fig. 3. Left part: inhibition of the steroidogenic activity of 
2 ng/ml ACTH by 3 different human plasma samples and 
plasma from hypophysectomized rats. Each plasma sample 
was shown to contain no ACTH. Right part: inhibition of 
adsorption of [ ‘25J]p _ ’ 24-ACTH to silicates by the same 
plasma sampies as in the keft part. There is a linear correlation 
between inhibition of steroidogenic activity and inhibition of 
adsorption (r = -0.9910). 
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Fig. 2. Radiochromatography of [ 1251]a’-39-ACTH incubated 
2 hr in: (1) BSA-NaCl, diluted 1:lO in rp RB buffer; (2) Hepar- 
in plasma, diluted 1: 10 KRB buffer with 1 mg/ml trypsin-in- 
hibitor; (3) Heparin plasma, diluted 1: 10 in KRB buffer with- 
out trypsin-inhibitor. Right upper part: 2 ng/ml unlabelled 
ACTH were incubated under the same conditions. 0.1 ml of 
solution (1) or 0.1 ml of QUSO-eluate from solution (2) and 
(3) were added to suspension of adrenal cells to assess the 
biologic activity. 
adrenal cells induced a remarkable inhibition of the 
steroidogenic activity of ACTH (fig. 1). Heparin in 
concentrations as they occur in these experiments was 
shown to be without effect. 
To estimate the influence of degradation of ACTH 
by proteolytic enzymes, [‘25J]~1-3g-ACTH was in- 
cubated in heparin plasma, dilutld 1: 10 in KRB- 
buffer with 1 mg/mi trypsin-inhibitor: radiochromato- 
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Table 1 
Behavior of ACTH and ‘inhibition factor’ during treatment of 
1.5 ml plasma with 50 mg QUSO G-32. 
Corticos- X 
terone 
~g/2 hr 
*S.D. 
Control with ACTH 
2 ng/vial 
+O.l ml hx Rat plasma 
+O.l ml QUSO supernatant 
from hx rat plasma 
+O.l QUSO eluate from 
hx rat plasma 
Control without ACTH 
+O. 1 ml QUSO eluate from 
hx rat plasma containing 
20 ng/ml ACTH 
2.44 2.42 0.17 
2.19 
2.62 
2.42 
1.46 1.49 0.04 
1.54 
1.46 
1.62 1.56 0.10 
1.58 
1;47 
2.58 2.52 0.10 
2.57 
2.42 
0.43 0.42 0.01 
0.42 
0.41 
0.43 
2.25 2.12 0.10 
2.03 
2.10 
2.09 
graphy revealed that only a negligible amount of 
ACTH was degraded in the presence of trypsin-in- 
hibitor as compared to the control (incubation in a 5% 
BSA-0.9% NaCl solution diluted 1: 10). On the other 
hand most of the ACTH was destroyed in the absence 
of trypsin-inhibitor (fig. 2). Furthermore, 2 ng/ml un- 
labelled ACTH were incubated under the same condi- 
tions and the biologic activity on isolated adrenal cells 
was assessed: 0.1 ml of the control incubate were as 
potent as 0.1 ml of the QUSO eluate derived from the 
incubate with plasma and trypsin-inhibitor, whereas 
most of the steroidogenic activity was destroyed by 
plasma in absence of trypsin-inhibitor (right upper 
part of fig. 2). 
The inhibitory activity differed from one plasma 
sample to the other, as did the binding activity (fig. 3). 
There was a linear correlation between these two 
activities: with increasing the binding activity also the 
inhibitory activity increased. 
Index of correlation in this experiment was 
r = -0.99 10. 
In contrast to ACTH the plasmatic inhibitory 
factor was not adsorbed to QUSO and remained in the 
supernatant (table 1). The QUSO eluate had no 
inhibitory activity. The stereoiodogenic activity of 0.1 
ml of the QUSO-eluate from hx rat plasma to which 
20 rig/ml ACTH had been added, was assessed correct- 
ly, The somewhat lower response was due to losses 
during extraction which have been estimated by tracer 
studies to amount constantly to 35%. 
4. Discussion 
A factor has been demonstrated in plasma which 
inhibits ACTH-mediated corticosterone production 
of isolated adrenal cells. This is in agreemmt with the 
findings of Sayers et al. [3] and Giordano and Sayers 
[7], whereas Kitabchi et al. [ 171 did not note inter- 
ference of ACTH action with plasma factors. The 
phenomena described by us might be the consequence 
of the degradation of ACTH by plasmatic proteolytic 
enzymes, as ACTH is destroyed rapidly in plasma [8]. 
Moreover, only slight alterations of the ACTH molecule 
as e.g. deamidation are followed by losses in biologic 
activity [9]. However, our results indicate that the 
trypsin-inhibitor preserved the chromatographic 
pattern of labelled ACTH as well as the biologic 
activity of unlabelled ACTH under the conditions 
employed. Accordingly degradation as the responsible 
cause could be excluded. 
The activity of the inhibitory factor differed from 
one plasma to the other. Thus valid measurement of 
plasma ACTH levels was impossible in the bioassay 
system using isolated adrenal cells. However, as the in- 
hibitory factor in contrast to ACTH is not adsorbed to 
QUSO, QUSO-extraction of ACTH from plasma success- 
fully circumvents this difficulty. 
From the studies presented, it might be presumed 
that binding and inhibitory activity are two aspects of 
the same plasma factor. This hypothesis is strongly 
supported by the fact that &ese two activities cor- 
related well. Of course, no actual proof can be offered 
unless the factor is isolates. 
There are many studies on the influence of plasma 
on different aspects of ACTH action [lo-161. It 
seems feasible to assume that at least some of them 
pertain to the same phenomenon as that described by 
us. There is a definite likelihood that the plasmatic 
ACTH-binding or inhibitory factor has important 
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implications on the function of the adrenal cortex, 
both physiologically and pathophysiologically. At 
this time. however. nothing definite can be cited to 
[8] Meakin, J.W., Tingey, W.H. Jr. and Nelson, D.H. (1960) 
Endocrinology 66, 59. 
[9] Graf, L., Hajds, G., Patthy, A. and Cseh, G. (1973) 
the physiological significance of this factor. Horm. Metab. Res. 5, 142. 
[IO] Segal, B.M. and Christy, N.P. (1968) J. Clin. Endocrinol. 
28, 1465. 
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